Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 6935054, 7 pages
https://doi.org/10.1155/2018/6935054
Research Article

Heart in Acromegaly: The Echocardiographic Characteristics of Patients Diagnosed with Acromegaly in Various Stages of the Disease

1Cardiology Clinic of Physiotherapy Division of the 2nd Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland
2Faculty of Health Sciences and Physical Education, Kazimierz Pulaski University of Technology and Humanities in Radom, Radom, Poland
3Department of Endocrinology, The Centre of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland
4Department of Cardiology, Bielanski Hospital, Warsaw, Poland

Correspondence should be addressed to Marek Dąbrowski; lp.dem.iksnaleib@adkeram

Received 7 October 2017; Revised 21 February 2018; Accepted 17 May 2018; Published 11 July 2018

Academic Editor: Jack Wall

Copyright © 2018 Agata Popielarz-Grygalewicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Zgliczyński, “Pituitary tumors,” in Internal Diseases, Part I, A. Szczeklik, Ed., pp. 1026–1028, Medycyna Praktyczna, Kraków, 2005. View at Google Scholar
  2. W. Zgliczyński, Progress in the Diagnosis and Treatment of the Hypothalamus and Hypophysis Diseases, Instytut Wydawniczy Książka i Prasa, Warszawa, 2003.
  3. K. Öberg and S. W. J. Lamberts, “Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future,” Endocrine-Related Cancer, vol. 23, no. 12, pp. R551–R566, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. T. J. Reid, K. D. Post, J. N. Bruce, M. Nabi Kanibir, C. M. Reyes-Vidal, and P. U. Freda, “Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed,” Clinical Endocrinology, vol. 72, no. 2, pp. 203–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. N. Clayton, “Cardiovascular function in acromegaly,” Endocrine Reviews, vol. 24, no. 3, pp. 272–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Fijałkowski, “Impact of acromegaly on the circulatory system,” Kardiologia po Dyplomie, vol. 12, pp. 33–36, 2013. View at Google Scholar
  7. I. Czajka-Oraniec and W. Zgliczyński, “Acromegaly and cardiovascular system,” Postępy Nauk Medycznych, vol. 25, pp. 866–871, 2012. View at Google Scholar
  8. A. Colao, G. Vitale, R. Pivonello, A. Ciccarelli, C. di Somma, and G. Lombardi, “The heart: an end-organ of GH action,” European Journal of Endocrinology, vol. 151, Supplement 1, pp. S93–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Manjila, O. C. Wu, F. R. Khan, M. M. Khan, B. M. Arafah, and W. R. Selman, “Pharmacological management of acromegaly: a current perspective,” Journal of Neurosurgery, vol. 29, no. 4, article E14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Găloiu and C. Poiană, “Current therapies and mortality in acromegaly,” Journal of Medicine and Life, vol. 8, no. 4, pp. 411–415, 2015. View at Google Scholar
  11. L. Rostomyan and A. Beckers, “Screening for genetic causes of growth hormone hypersecretion,” Growth Hormone & IGF Research, vol. 30-31, pp. 52–57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Malicka, J. Świrska, M. Kurowska, M. Dudzińska, and J. S. Tarach, “Familial isolated pituitary adenomas (FIPA). Case report of four families and review of literature,” Endokrynologia Polska, vol. 68, no. 6, pp. 697–707, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. W. P. Bandettini, A. S. Karageorgiadis, N. Sinaii et al., “Growth hormone and risk for cardiac tumors in Carney complex,” Endocrine-Related Cancer, vol. 23, no. 9, pp. 739–746, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Giusti, F. Marini, and M. L. Brandi, “Multiple endocrine neoplasia type 1,” Source GeneReviews®, M. P. Adam, H. H. Ardinger, R. A. Pagon et al., Eds., University of Washington, Seattle, WA, USA, 2005. View at Google Scholar
  15. G. Lugo, L. Pena, and F. Cordido, “Clinical manifestations and diagnosis of acromegaly,” International Journal of Endocrinology, vol. 2012, Article ID 540398, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Tykarski, K. Widecka, and K. J. Filipiak, “Polish Society of Hypertension: guidelines for the management of arterial hypertension-2015. Comments and reasons for changes,” Nadciśnienie Tętnicze w Praktyce, vol. 2, pp. 71–94, 2015. View at Google Scholar
  17. M. Olszanecka-Glinianowicz, L. Czupryniak, and the writing group, “2017 guidelines on the management of diabetic patients. A position of Diabetes Poland,” Diabetologia Praktyczna, vol. 3, supplement A, pp. A5–A6, 2017. View at Google Scholar
  18. R. B. Devereux, D. R. Alonso, E. M. Lutas et al., “Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings,” The American Journal of Cardiology, vol. 57, no. 6, pp. 450–458, 1986. View at Publisher · View at Google Scholar · View at Scopus
  19. S. F. Nagueh, C. P. Appleton, T. C. Gillebert et al., “Recommendations for the evaluation of left ventricular diastolic function by echocardiography,” European Journal of Echocardiography, vol. 10, no. 2, pp. 165–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. F. Nagueh, O. A. Smiseth, C. P. Appleton et al., “Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging,” Journal of the American Society of Echocardiography, vol. 29, no. 4, pp. 277–314, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. R. B. Willenheimer, B. A. Israelsson, C. M. J. Cline, and L. R. Erhardt, “Simplified echocardiography in the diagnosis of heart failure,” Scandinavian Cardiovascular Journal, vol. 31, no. 1, pp. 9–16, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. G. D. Cole, N. M. Dhutia, M. J. Shun-Shin et al., “Defining the real-world reproducibility of visual grading of left ventricular function and visual estimation of left ventricular ejection fraction: impact of image quality, experience and accreditation,” The International Journal of Cardiovascular Imaging, vol. 31, no. 7, pp. 1303–1314, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. R. M. Lang, L. P. Badano, V. Mor-Avi et al., “Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging,” European Heart Journal – Cardiovascular Imaging, vol. 16, no. 3, pp. 233–271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. dos Santos Silva, I. Gottlieb, I. Volschan et al., “Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort,” The Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 12, pp. 4447–4455, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. P. K. Fazeli, J. G. Teoh, E. L. Lam et al., “Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly,” Growth Hormone & IGF Research, vol. 26, pp. 17–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Colao, “Improvement of cardiac parameters in patients with acromegaly treated with medical therapies,” Pituitary, vol. 15, no. 1, pp. 50–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Fazio, A. Cittadini, D. Sabatini et al., “Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study,” European Heart Journal, vol. 14, no. 1, pp. 26–33, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Fazio, D. Sabatini, A. Cittadini et al., “Growth hormone and the heart,” Cardiologia, vol. 38, no. 8, pp. 513–518, 1993. View at Google Scholar
  29. X. Guo, L. Gao, S. Zhang et al., “Cardiovascular system changes and related risk factors in acromegaly patients: a case–control study,” International Journal of Endocrinology, vol. 2015, Article ID 573643, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Vilar, C. F. Vilar, R. Lyra, R. Lyra, and L. A. Naves, “Acromegaly: clinical features at diagnosis,” Pituitary, vol. 20, no. 1, pp. 22–32, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Geyer, G. Caracciolo, H. Abe et al., “Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications,” Journal of the American Society of Echocardiography, vol. 23, no. 4, pp. 351–369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Manovel, D. Dawson, B. Smith, and P. Nihoyannopoulos, “Assessment of left ventricular function by different speckle-tracking software,” European Journal of Echocardiography, vol. 11, no. 5, pp. 417–421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. L. F. Tops, V. Delgado, N. A. Marsan, and J. J. Bax, “Myocardial strain to detect subtle left ventricular systolic dysfunction,” European Journal of Heart Failure, vol. 19, no. 3, pp. 307–313, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Uziębło-Życzkowska, P. Krzesinński, P. Witek et al., “Cushing’s disease: subclinical left ventricular systolic and diastolic dysfunction revealed by speckle tracking echocardiography and tissue Doppler imaging,” Frontiers in Endocrinology, vol. 8, p. 222, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. M. J. Varghese, G. Sharma, G. Shukla et al., “Longitudinal ventricular systolic dysfunction in patients with very severe obstructive sleep apnea: a case control study using speckle tracking imaging,” Indian Heart Journal, vol. 69, no. 3, pp. 305–310, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. I. C. M. Volschan, L. Kasuki, C. M. S. Silva et al., “Two-dimensional speckle tracking echocardiography demonstrates no effect of active acromegaly on left ventricular strain,” Pituitary, vol. 20, no. 3, pp. 349–357, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Colao and L. F. S. Grasso, “Aortic root ectasia in patients with acromegaly, an emerging complication,” Clinical Endocrinology, vol. 75, no. 4, pp. 420-421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. D’Andrea, E. Bossone, J. Radmilovic et al., “Exercise-induced atrial remodeling: the forgotten chamber,” Cardiology Clinics, vol. 34, no. 4, pp. 557–565, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Sartorio, P. Morpurgo, V. Cappiello et al., “Exercise-induced effects on growth hormone levels are associated with ghrelin changes only in presence of prolonged exercise bouts in male athletes,” Journal of Sports Medicine and Physical Fitness, vol. 48, no. 1, pp. 97–101, 2008. View at Google Scholar